Showing results (231-240 of 244) with videos related to
Sort By:
Pageof 25
Haematologica|June 30, 2022
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphomaMi Kwon, Gloria Iacoboni, Juan Luis Reguera, et al.Translational Stroke Research|September 29, 2021
Monocyte-to-Lymphocyte Ratio in Clot Analysis as a Marker of Cardioembolic Stroke EtiologyJesús Juega, Carlos Palacio-Garcia, Maite Rodriguez, et al.Molecular Ecology|September 28, 2016
Global genetic diversity of Aedes aegyptiAndrea Gloria-Soria, Diego Ayala, Ambicadutt Bheecarry, et al.Journal of Minimally Invasive Gynecology|February 14, 2015
How to Manage Bowel Endometriosis: The ETIC ApproachGiulia Alabiso, Luigi Alio, Saverio Arena, et al.Journal of Hematology & Oncology|October 29, 2024
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatmentGloria Iacoboni, Víctor Navarro, Pierre Sesques, et al.Cancers|June 2, 2021
Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study AnalysisMaria Barca-Hernando, Andres J Muñoz-Martin, Eduardo Rios-Herranz, et al.Mitochondrial DNA. Part B, Resources|January 25, 2021
Analysis of the complete organellar genomes of the rockweed <i>Fucus spiralis</i> (Fucaceae, Phaeophyceae) supports its infraspecific recognition as <i>Fucus vesiculosus</i> var. <i>spiralis</i>Alejandra Alvarez, Juan Anaya, Bibiana Arellano, et al.The Lancet. Oncology|January 31, 2012
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trialRafael Rosell, Enric Carcereny, Radj Gervais, et al.The Journal of Allergy and Clinical Immunology|February 18, 2026
PrecISE- A Biomarker Stratified Adaptive Trial of 5 Interventions in Severe Asthma: Final Protocol and the Baseline CohortLoren C Denlinger, Elliot Israel, Wendy C Moore, et al.The Journal of Allergy and Clinical Immunology|December 1, 2021
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventionsSteve N Georas, Rosalind J Wright, Anastasia Ivanova, et al.Pageof 25